Jafra Royal Jelly Revitalize
Product Images NDC 68828-500

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Jafra Royal Jelly Revitalize (NDC 68828-500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jafra Cosmetics International, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tube Back (Revitalizetubes Back)

Tube Back (Revitalizetubes Back)
Drug Facts panel of Jafra Royal Jelly Revitalize showing active ingredients Avobenzone 3%, Homosalate 10%, Octisalate 5%, and Octocrylene 7% as sunscreens. Warnings include external use only, discontinue if rash occurs, and keep out of reach of children. Directions for use advise applying 15 minutes before sun exposure and reapplying every 2 hours. List of inactive ingredients and additional product use information are also shown.*
FDA Label Image

Tube Front (Revitalizetubes Front)

Tube Front (Revitalizetubes Front)
Packaging label for Jafra Royal Jelly Revitalize by JAFRA COSMETICS INTERNATIONAL. The label includes product branding with a smiling woman, text promoting skin vitality, and details an exclusive Royal Jelly RJX formula. It lists sample contents including Gentle Cleansing Milk 30 ml, Longevity Crème 14 ml, Spot Serum 7.5 ml, and Solar Protection Fluid SPF 50 14 ml. Usage instructions and ingredient information for the Longevity Crème are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.